
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors
Marius Bredon, Camille Danne, Hang‐Phuong Pham, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Marius Bredon, Camille Danne, Hang‐Phuong Pham, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Showing 14 citing articles:
The gut microbiome and cancer response to immune checkpoint inhibitors
Francesca S. Gazzaniga, Dennis L. Kasper
Journal of Clinical Investigation (2025) Vol. 135, Iss. 3
Open Access | Times Cited: 2
Francesca S. Gazzaniga, Dennis L. Kasper
Journal of Clinical Investigation (2025) Vol. 135, Iss. 3
Open Access | Times Cited: 2
Effect of diet and lifestyle on microbiome composition
R. K. Gupta, Smriti Gaur
International review of cell and molecular biology (2025)
Closed Access
R. K. Gupta, Smriti Gaur
International review of cell and molecular biology (2025)
Closed Access
Oncobiomics: Leveraging Microbiome Translational Research in Immuno-Oncology for Clinical-Practice Changes
Carolina Alves Costa Silva, Andrew A. Almonte, Laurence Zitvogel
Biomolecules (2025) Vol. 15, Iss. 4, pp. 504-504
Open Access
Carolina Alves Costa Silva, Andrew A. Almonte, Laurence Zitvogel
Biomolecules (2025) Vol. 15, Iss. 4, pp. 504-504
Open Access
Coupling culturomics and metagenomics sequencing to characterize the gut microbiome of patients with cancer treated with immune checkpoint inhibitors
Khoudia Diop, Babacar Mbaye, Somayeh Nili, et al.
Gut Pathogens (2025) Vol. 17, Iss. 1
Open Access
Khoudia Diop, Babacar Mbaye, Somayeh Nili, et al.
Gut Pathogens (2025) Vol. 17, Iss. 1
Open Access
Impact of the ONCOBIOME network in cancer microbiome research
Laurence Zitvogel, Lisa Derosa, Bertrand Routy, et al.
Nature Medicine (2025)
Closed Access
Laurence Zitvogel, Lisa Derosa, Bertrand Routy, et al.
Nature Medicine (2025)
Closed Access
Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship
Arielle Elkrief, Bertrand Routy, Lisa Derosa, et al.
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 3
Closed Access
Arielle Elkrief, Bertrand Routy, Lisa Derosa, et al.
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 3
Closed Access
Faecalibacterium prausnitzii induces an anti-inflammatory response and a metabolic reprogramming in human monocytes
Camille Danne, Laura Creusot, Rodrigo de Oliveira Formiga, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Camille Danne, Laura Creusot, Rodrigo de Oliveira Formiga, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Faecalibacterium prausnitzii is associated with clinical response to immune checkpoint inhibitors in patients with advanced gastric adenocarcinoma: results of microbiota analysis of PRODIGE 59-FFCD 1707-DURIGAST trial
Marius Bredon, Karine le Malicot, Christophe Louvet, et al.
Gastroenterology (2024)
Open Access | Times Cited: 2
Marius Bredon, Karine le Malicot, Christophe Louvet, et al.
Gastroenterology (2024)
Open Access | Times Cited: 2
Narrative Review: Advancing Dysbiosis Treatment in Onco-Hematology with Microbiome-Based Therapeutic Approach
Salomé Biennier, Mathieu Fontaine, Aurore Duquenoy, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2256-2256
Open Access | Times Cited: 2
Salomé Biennier, Mathieu Fontaine, Aurore Duquenoy, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2256-2256
Open Access | Times Cited: 2
Oncolytic Virotherapies and Adjuvant Gut Microbiome Therapeutics to Enhance Efficacy Against Malignant Gliomas
Natalie M. Meléndez-Vázquez, Candelaria Gomez‐Manzano, Filipa Godoy‐Vitorino
Viruses (2024) Vol. 16, Iss. 11, pp. 1775-1775
Open Access | Times Cited: 2
Natalie M. Meléndez-Vázquez, Candelaria Gomez‐Manzano, Filipa Godoy‐Vitorino
Viruses (2024) Vol. 16, Iss. 11, pp. 1775-1775
Open Access | Times Cited: 2
Identification of hsa-miR-193a-5p-SURF4 axis related to the gut microbiota-metabolites- cytokines in lung cancer based on Mendelian randomization study and bioinformatics analysis
Jie Yu, Sibo Meng, Tiantian Xuan, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Jie Yu, Sibo Meng, Tiantian Xuan, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Study of Microbiota Associated to Early Tumors Can Shed Light on Colon Carcinogenesis
Anna Aspesi, Marta La Vecchia, G. Sala, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13308-13308
Open Access | Times Cited: 1
Anna Aspesi, Marta La Vecchia, G. Sala, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13308-13308
Open Access | Times Cited: 1
Faecalibacterium prausnitzii: one species with multiple potential implications in cancer research
Rodrigo de Oliveira Formiga, Harry Sokol
Gut (2024), pp. gutjnl-334338
Closed Access | Times Cited: 1
Rodrigo de Oliveira Formiga, Harry Sokol
Gut (2024), pp. gutjnl-334338
Closed Access | Times Cited: 1
The landscape of new therapeutic opportunities for IBD
Andrés Hurtado-Lorenzo, Jennifer L Swantek
Advances in pharmacology (2024), pp. 1-83
Closed Access
Andrés Hurtado-Lorenzo, Jennifer L Swantek
Advances in pharmacology (2024), pp. 1-83
Closed Access
Quoi de neuf en recherche ?
Alexandra–Chloé Villani
Annales de Dermatologie et de Vénéréologie - FMC (2024) Vol. 4, Iss. 8, pp. 8S13-8S20
Closed Access
Alexandra–Chloé Villani
Annales de Dermatologie et de Vénéréologie - FMC (2024) Vol. 4, Iss. 8, pp. 8S13-8S20
Closed Access